Future Medicine Co., Ltd. (XKON: 341170)
South Korea
· Delayed Price · Currency is KRW 1,900.00
0.00 (0.00%)
At close: Sep 10, 2024
Future Medicine Statistics
Total Valuation
Future Medicine has a market cap or net worth of KRW 17.62 billion.
| Market Cap | 17.62B |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Future Medicine has 9.28 million shares outstanding.
| Shares Outstanding | 9.28M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +35.88% |
| Owned by Insiders (%) | 15.35% |
| Owned by Institutions (%) | 3.90% |
| Float | 7.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.51 |
| PB Ratio | 2.70 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.62, with a Debt / Equity ratio of 3.47.
| Current Ratio | 9.62 |
| Quick Ratio | 9.08 |
| Debt / Equity | 3.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.03 |
| Interest Coverage | -4.55 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Future Medicine had revenue of KRW 1.00 billion and -13.37 billion in losses. Loss per share was -1,637.42.
| Revenue | 1.00B |
| Gross Profit | 1.00B |
| Operating Income | -7.09B |
| Pretax Income | -13.37B |
| Net Income | -13.37B |
| EBITDA | -6.64B |
| EBIT | -7.09B |
| Loss Per Share | -1,637.42 |
Balance Sheet
The company has 5.41 billion in cash and 226.27 million in debt, giving a net cash position of 5.18 billion or 558.86 per share.
| Cash & Cash Equivalents | 5.41B |
| Total Debt | 226.27M |
| Net Cash | 5.18B |
| Net Cash Per Share | 558.86 |
| Equity (Book Value) | 6.52B |
| Book Value Per Share | 703.11 |
| Working Capital | 5.21B |
Cash Flow
In the last 12 months, operating cash flow was -7.09 billion and capital expenditures -110.72 million, giving a free cash flow of -7.20 billion.
| Operating Cash Flow | -7.09B |
| Capital Expenditures | -110.72M |
| Free Cash Flow | -7.20B |
| FCF Per Share | -776.78 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -708.92% |
| Pretax Margin | -1,336.67% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -720.50% |
Dividends & Yields
Future Medicine does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -86.18% |
| FCF Yield | -40.88% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |